Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07048067 · ClinicalTrials.gov registry record

Ultrasound Evaluation for Baxter VASCU-GUARD Vascular Patches Post-Endarterectomy and Complications Assessment

A clinical trial, sponsored by The Methodist Hospital Research Institute.

Completed
Registry status
500
Enrollment target

NCT07048067 is a clinical trial that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 500 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07048067 has completed, sponsored by The Methodist Hospital Research Institute.

COMPLETED
Registry status
500 participants
Enrollment target

Study Summary

VASCU-GUARD vascular patches with the new packaging have been available at the Houston Methodist Hospital since January 2023. This study is a retrospective chart review, aiming to compare the performance of Baxter VASCU-GUARD vascular patches implemented during carotid endarterectomies (CEA) prior to January 2023 and after January 2023. This study is one of a kind, as no other comparative retrospective chart review on the performance of VASCU-GUARD vascular patches from the old and new packaging has been published yet. The project will contribute to the scientific knowledge about long-term outcomes associated with the use of patch material during endarterectomies.

Interventions

  • PROCEDURE Carotid endarterectomy (CEA)

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2023-01-01
Est. Completion 2025-02-01

What the Registry Record Tells You About NCT07048067

The ClinicalTrials.gov registry entry for NCT07048067 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Carotid endarterectomy (CEA) is the first listed.

NCT07048067 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07048067 about?

NCT07048067 is a clinical study titled "Ultrasound Evaluation for Baxter VASCU-GUARD Vascular Patches Post-Endarterectomy and Complications Assessment". VASCU-GUARD vascular patches with the new packaging have been available at the Houston Methodist Hospital since January 2023. This study is a retrospective chart review, aiming to compare the performance of Baxter VASCU-GUARD vascular patches implemented during carotid endarterectomies (CEA) prior t...

What is the current status of trial NCT07048067?

This trial is currently completed. The enrollment target is 500 participants. The study started on 2023-01-01. Estimated completion is 2025-02-01.

What interventions are being tested in trial NCT07048067?

The interventions under investigation include: Carotid endarterectomy (CEA) (PROCEDURE).

Who is sponsoring clinical trial NCT07048067?

This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.